Centene Corporation CNC
- Market cap
- $30.6B
- P/E
- 0.0×
Follow CNC
Centene Corporation (CNC) Free cash flow
Centene Corporation's free cash flow for fiscal 2025 was $4.3B, compared with −$490.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was $9.0B. Over the past ten years it has ranged from −$490.0M (fiscal 2024) to $7.3B (fiscal 2023); the current reading is higher than 73% of that period. Centene Corporation ranks 4th of 12 Healthcare Plans companies by free cash flow.
Free cash flow, annual
Annual
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $4.3B | — |
| FY2024 | −$490.0M | — |
| FY2023 | $7.3B | 37.99% |
| FY2022 | $5.3B | 59.54% |
| FY2021 | $3.3B | (28.90%) |
| FY2020 | $4.6B | 515.41% |
| FY2019 | $753.0M | 34.70% |
| FY2018 | $559.0M | (47.61%) |
| FY2017 | $1.1B | (30.94%) |
| FY2016 | $1.5B | 204.13% |
Quarterly
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $3.4B | (18.00%) |
| Mar 2026 | $4.2B | 1,759.82% |
| Dec 2025 | $224.0M | (80.44%) |
| Sep 2025 | $1.1B | (27.39%) |
| 42 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $23.6B |
| CVS CVS Health Corporation compare | $11.8B |
| CI Cigna Group compare | $9.1B |
| CNC Centene Corporation | $9.0B |
| ELV Elevance Health, Inc. compare | $6.3B |
| OSCR Oscar Health, Inc. compare | $4.4B |
| HUM Humana Inc. compare | $2.0B |
| MOH Molina Healthcare, Inc compare | $271.0M |
| CLOV Clover Health Investments, Corp. compare | $74.2M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on CNC
- Revenue
- Net income
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement